205 related articles for article (PubMed ID: 20100855)
1. Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia.
Diaz MH; Hauser AR
Infect Immun; 2010 Apr; 78(4):1447-56. PubMed ID: 20100855
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.
Diaz MH; Shaver CM; King JD; Musunuri S; Kazzaz JA; Hauser AR
Infect Immun; 2008 Oct; 76(10):4414-21. PubMed ID: 18663007
[TBL] [Abstract][Full Text] [Related]
3. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia.
Howell HA; Logan LK; Hauser AR
mBio; 2013 Mar; 4(2):e00032-13. PubMed ID: 23481600
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis.
Machado GB; de Oliveira AV; Saliba AM; de Lima CD; Suassuna JH; Plotkowski MC
Respir Res; 2011 Aug; 12(1):104. PubMed ID: 21819560
[TBL] [Abstract][Full Text] [Related]
7. Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.
Veesenmeyer JL; Howell H; Halavaty AS; Ahrens S; Anderson WF; Hauser AR
Infect Immun; 2010 Aug; 78(8):3346-57. PubMed ID: 20479080
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.
Tam C; Lewis SE; Li WY; Lee E; Evans DJ; Fleiszig SM
Exp Eye Res; 2007 Dec; 85(6):799-805. PubMed ID: 17905228
[TBL] [Abstract][Full Text] [Related]
9. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.
Koh AY; Priebe GP; Ray C; Van Rooijen N; Pier GB
Infect Immun; 2009 Dec; 77(12):5300-10. PubMed ID: 19805527
[TBL] [Abstract][Full Text] [Related]
10. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.
Schulert GS; Feltman H; Rabin SD; Martin CG; Battle SE; Rello J; Hauser AR
J Infect Dis; 2003 Dec; 188(11):1695-706. PubMed ID: 14639541
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.
Sato H; Frank DW; Hillard CJ; Feix JB; Pankhaniya RR; Moriyama K; Finck-Barbançon V; Buchaklian A; Lei M; Long RM; Wiener-Kronish J; Sawa T
EMBO J; 2003 Jun; 22(12):2959-69. PubMed ID: 12805211
[TBL] [Abstract][Full Text] [Related]
12. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
Shaver CM; Hauser AR
Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
[TBL] [Abstract][Full Text] [Related]
13. ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis.
da Cunha LG; Ferreira MF; de Moraes JA; Reis PA; Castro-Faria-Neto HC; Barja-Fidalgo C; Plotkowski MC; Saliba AM
Med Microbiol Immunol; 2015 Dec; 204(6):673-80. PubMed ID: 25904542
[TBL] [Abstract][Full Text] [Related]
14. ExoU activates NF-κB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection.
de Lima CD; Calegari-Silva TC; Pereira RM; Santos SA; Lopes UG; Plotkowski MC; Saliba AM
PLoS One; 2012; 7(7):e41772. PubMed ID: 22848596
[TBL] [Abstract][Full Text] [Related]
15. Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia.
Gates KL; Howell HA; Nair A; Vohwinkel CU; Welch LC; Beitel GJ; Hauser AR; Sznajder JI; Sporn PH
Am J Respir Cell Mol Biol; 2013 Nov; 49(5):821-8. PubMed ID: 23777386
[TBL] [Abstract][Full Text] [Related]
16. Association of the exoU genotype with a multidrug non-susceptible phenotype and mRNA expressions of resistance genes in Pseudomonas aeruginosa.
Takata I; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):45-52. PubMed ID: 29107652
[TBL] [Abstract][Full Text] [Related]
17. Distinct contributions of interleukin-1α (IL-1α) and IL-1β to innate immune recognition of Pseudomonas aeruginosa in the lung.
Al Moussawi K; Kazmierczak BI
Infect Immun; 2014 Oct; 82(10):4204-11. PubMed ID: 25069982
[TBL] [Abstract][Full Text] [Related]
18. ExoU modulates soluble and membrane-bound ICAM-1 in Pseudomonas aeruginosa-infected endothelial cells.
Lins RX; de Assis MC; Mallet de Lima CD; Freitas C; Maciel Plotkowski MC; Saliba AM
Microbes Infect; 2010 Feb; 12(2):154-61. PubMed ID: 19931407
[TBL] [Abstract][Full Text] [Related]
19. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
Lee VT; Smith RS; Tümmler B; Lory S
Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
[TBL] [Abstract][Full Text] [Related]
20. Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU.
Saliba AM; de Assis MC; Nishi R; Raymond B; Marques Ede A; Lopes UG; Touqui L; Plotkowski MC
Microbes Infect; 2006 Feb; 8(2):450-9. PubMed ID: 16293434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
